ABSTRACT
Lonicera hypoglauca Miq. is used in the traditional medicine for the treatment of sore throat infection, respiratory tract infection and intestinal tract diseases indicating antimicrobial activity. To validate the traditional medicinal claim, in vitro antimicrobial activity of the extracts was screened against eleven human pathogenic bacteria and fungi.The ethyl acetate (EE) and n-butanol (BE) extracts of the flower of Lonicera hypoglauca Miq were tested against five Gram-positive bacteria, five Gram-negative bacteria and five fungi species. Antimicrobial activity was determined by the tube-dilution method. The EE and BE extracts showed antimicrobial activity against all of the tested microorganisms, with minimum inhibitory concentration (MIC) values in the range of 0.32-4.86 mg/ml. The tested microbes Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pneumoniae were highly susceptible to extract BE and antimicrobial activity of extract BE is better than that of extract EE against Staphylococcus aureus and Streptococcus pneumoniae. Both the extracts were found less susceptible against tested fungi.
KEYWORDS: Antimicrobial; Extracts; Lonicera hypoglauca Miq.
INTRODUCTION
The plants of the genus Lonicera hypoglauca Miq (Caprifoliaceae) wildly grows and is also cultivated in southern area of China, especially in Hunan province. Flos Lonicera of Lonicera hypoglauca Miq is a common Chinese medicinal herb which has a long history of indigenous use in China. Leaves and flower of Lonicera hypoglauca Miq possess antibacterial activity in Chinese medicine, Flos Lonicera of Lonicera hypoglauca Miq Jinyinhua and Lonicera japonica Thunb both called Jinyinhua that is well-known Chinese traditional medicine for the treatment of diverse diseases (Yin et. al., 2007, Su, 2009), especially for the treatment of sore throat infection and respiratory tract infection and intestinal tract infection diseases. In china, the leaves and flowers are boiled and administered to patient, especially Flos Lonicera (flower). It has attracted many interests.
Both Lonicera hypoglauca Miq. and Lonicera japonica Thunb are widely used as Jinyinhua in traditional Chinese medicine. Although they have similar geographic distribution, obviously various characteristics are observed (Pu et. al., 2002). Studies of the phytochemistry and bioactivity of Jinyinhua have mostly focused on L. japonica (Japanese honeysuckle) that has been reported to possess properties like anti-inflammatory, antiangiogenic and anti-nociceptive activities (Xu et. al., 2007, Yoo et. al., 2008).
Studies have been also reported on the phytochemistry of Lonicera hypoglauca Miq. Ziguglycoside, scopoletin, daucosterol, â-sitosterol have been isolated from ethyl acetate, and macranthoidin A, macranthoidin B, chlorogenic acid have been isolated from n-butanol extracts of rattan of Lonicera hypoglauca Miq (He et. al., 2006). Hexadecanoic acid, Docosane,Linoleic acid have also been reported from the essential oil of this plant (Guo,et. al.,2005). However, the bioactivity of Lonicera hypoglauca Miq. has barely been studied.
The micro-organisms which are often associated with throat, respiratory tract and intestinal tract infectious diseases belong to the genus bacillus and coccus. These organisms are present in water, soil, sewage and in the gastrointestinal tract of animals, included humans (Murray et. al., 1998). As part of our contribution to phytochemical and biological survey and to validation of traditional uses of this medicinal plant we report herein the study on Flos Lonicera of Lonicera hypoglauca Miq antimicrobial activity.
In particular, the purpose of this study was to investigate the plant for the potential antimicrobial activity against selected bacterial strains, which may be involved in sore throat diseases and softtissue infections, especially respiratory tract infection. Further bioassay-guided extractions were carried out in ethyl acetate extract and n-butanol, in order to obtain the most active extract with the final aim to identify the chemical classes responsible for the biological activity.
Materials & Methoda
Experimental Chemicals and reagents
HPLC-grade ethyl acetate and n-butanol were purchased from Changsha Sheng Fan reagents Co., LTD, (Changsha, China); Norfloxacin and Fluconcazole were purchased from Shanghai research born biochemical reagents Co., LTD, China; water was deionized byfiltering through a Direct-Q system (Millipore, Bedford, MA, USA).
Plant material
Flos Lonicera (flower) of Lonicera hypoglauca Miq was collected in the month of June 2010 from HuNan, China. The botanical identification of the plant was done at Food and biology Department, Science & Technology University, Chang Sha, HuNan, china. A voucher specimen (no.FLHM01) has also been deposited at Food and biology Department, Science & Technology University, Chang Sha. Flos Lonicera (flower) was dried in the dark, in a ventilate room at 25-30°C, then grounded and the powder stored at -20°C.
Extraction
Flos Lonicera (flower) of Lonicera hypoglauca Miq was dried and coarsely powdered by grinding. The powdered material (200 g) was extracted with 2 l of ethyl acetate and n-butanol separately. Each filtrate was concentrated under reduced pressure at 50°C. The extracts were further dried at room temperature under reduced pressure. The yield of the extracts of ethyl acetate (EE) and n-butanol (BE) were 1.90 g (w/w) and 3.40 g (w/w), respectively.
Antimicrobial activity
Micro-organisms
The micro-organisms which are often associated with throat, respiratory tract and intestinal tract infectious diseases belong to the genus bacillus and coccus. The following strains were used for testing the antimicrobial activity of the crude extracts: Staphylococcus aureus (26003 ), alpha hemolytic streptococcus (32129), beta hemolytic streptococcus (53214), Streptococcus pneumoniae (32010), Corynebacterium diphtheriae (38101) (Gram-positive bacteria), Shigella flexneri (51236), Salmonellaty phimurium (53185), Escherichia coli (44104), Pseudomonas aeruginosa (10223), Bacillus subtilis (63501) (Gram-negative bacteria) were obtained from the health ministry identified microbes, Beijin, China. Candida albicans (ATCC 11006), Candida parapsilosis (ATCC22019), Candida tropicalis (ATCC01463), Trichophyton mentagrophytes (ATCC28185), Cryptococcus neoformans (ATCC32609) (Fungi) were obtained from Beijing university fungi and fungal disease research center, China.
Preparation of test sample
The EE and BE extracts were dissolved in 10% N-N dimethyl formamide (DMF) which is reported to be non-toxic to microorganisms at this percentage (Pujol et. al., 1990). Norfloxacin and Fluconcazole (Shanghai research born biochemical reagents Co., LTD, China) were used as positive reference standards for bacterial and fungal strains, respectively.
Preparation of inocula
The inocula of microbial strains were prepared from 18 h old culture and suspensions were adjusted to 0.5 McFarland standard turbidity (~104 for bacteria and ~103 for fungi colony forming unit (CFU) per milliliter) (McFarland, 1987).
Evaluation of minimum inhibitory concentration (MIC)
Tube-dilution method was used to determine the minimum inhibitory concentration (MIC) of the EE and BE extracts against the microorganisms under study. The EE and BE extracts were dissolved in 10% N-N dimethyl formamide (DMF). The final concentrations of EE and BE extracts for bacteria were 4.0 and 6.0 mg/ml, respectively. The final concentration 5.0 mg/ml was used for EE and BE extracts against fungi. Serial two-fold dilutions were prepared from the stock solution to give concentration ranging from 4.00-0.006 to 6.0-0.008 mg/ml for EE and BE extracts, respectively against bacterial strains. The concentration range (5.0-0.008 mg/ml) of EE and BE extracts was evaluated against fungal strains. Norfloxacin and Fluconazole were dissolved in sterile distilled water and two-fold dilutions were prepared (1.0-0.002 mg/ml). One ml of each concentration was mixed with 1.0 ml of sterile peptone water (104 CFU/ml for bacteria and 103 CFU/ml for fungal concentration, obtained from a McFarland turbidity standard no. 0.5). Solvent control was prepared with DMF (10%) and blank control was prepared from virgin media. Tubes were incubated for 24 and 48 h at 37°C for bacteria and fungi, respectively. Assay was performed in replicates and the mean value of three experiments was recorded (n = 3) with standard deviation. MIC was determined as the lowest concentration that inhibits the visible microbial growth (Murthy et. al., 2006; Kuta, 2008).
RESULTS AND DISCUSSION
The antimicrobial activity expressed as mg/ml, of the two extracts of the flower of Lonicera hypoglauca Miq against various strains of bacteria and fungi are summarized in Table 1. The organisms Staphylococcus aureus and Streptococcus pneumoniae were found to be most susceptible to the extract BE and EE in bacteria strains with MIC values of 0.32 ± 0.11, 0.41 ± 0.19, 0.46 ± 0.14 and 0.53 ± 0.17 respectively. The organisms Corynebacterium diphtheriae, beta hemolytic streptococcus and alpha hemolytic streptococcus was found more susceptible to the extract BE and EE with lower MIC value (<1.0 mg/ml), While the organisms Shigella flexneri, Salmonellaty phimurium, Escherichia coli, Pseudomonas aeruginosa and Bacillus subtilis were less susceptible and showed higher MIC values (MIC > 1.0 mg/ml).
The extract BE was effective against Candida albicans with MIC value of 1.96 ± 0.69. The MIC values more than 2.0 mg/ml were observed against Candida albicans and Candida parapsilosis for extract EE, and Candida parapsilosis for extract BE. The MIC values of more than 3.0 mg/ml were observed against Candida tropicalis, Trichophyton mentagrophytes and Cryptococcus neoformans. for extract BE, and Candida tropicalis for extract EE, while MIC values of the extract EE were found more than 4.0 mg/ml against Trichophyton mentagrophytes and Cryptococcus neoformans. Both the extracts were found to be less effective than the standard antibiotics used in the present study and their efficacy was least against fungi (Table 1). The experiment results suggested that the extracts have antimicrobial activities. The benefit of local application of the flower of Lonicera hypoglauca Miq as the treatment of sore throat and respiratory tract infection in Chinese could be attributed to their antimicrobial activity as observed in this study.
ACKNOWLEDGEMENTS
The authors are grateful to Prof. G.M. Li, Department of Food and Biology, College of Chemistry and Biology Chang Sha University of Science & Technology, for identification of the plant. This work was supported by hunan Provincial Education Department (12A008 and 10C0399).
To Cite this article:
Xiao-Shun Shu, Jin-Hai Lv, Dong-Ming Chen, Yun-Hui Chen (2012), ANTIMICROBIAL ACTIVITY OF THE EXTRACTS FROM LONICERA HYPOGLAUCA MIQ. ETHNOPHARMACOLOGICAL COMMUNICATION, Global J Res. Med. Plants & Indigen. Med., Volume 1(12), 650-655
REFERENCES
Gou, Z.P.,Wan De-Guang.,(2005), Studies of the chemical constituents of volatile oils from the dry flower buds of Lonicera hypoglauca. Chin JMAP 6;475-476.
He, Q.H., Li, H.J., Bi, Z.M., Li,S.P. and Ma,S.Z.,2006. Chemical Constituents in the Stem of Lonicera hypoglauca. Chin J Nat Med 5; 385-386.
Kuta, F.A., (2008). Antifungal effect of Calotropis procera stem bark on Epidermophyton flocosum and Trichophyton gypseum. African Journal of Biotechnology 7, 2116-2118.
McFarland, J., (1987). Standardization of bacterial culture for the disc diffusion assay. Journal of American Medical Association 49, 1176-1178.
Murthy, M.M., Subramanyam, M., Giridhar, K.V., Jetty, A., (2006). Antimicrobial activities of bharangin from Premna herbacea Roxb. and bharangin monoactate. Journal of Ethnopharmacology 104, 290-292.
Murray, R.P., Rosenthal, K.S., Kobayashi, S.G., Pfaller, A.M., 1998. Medical Microbiology, vol. 37. Mosby, St. Louis, MO, pp. 296-298.
Pujol, V., Seux, V., Villard, J., (1990). Recherche de substances Anti-fongiques secretes par les champignons superieurs en culture. Annales Pharmaceutiques Francaises 48, 17-22.
Pu, Z., Xing, J., Li, P., Liu, T., Wang, Z., (2002), Studies on the floral morphology of Flos Lonicerae, Zhong Yao Cai 25, 854-859.
Su, S.Y., 2009. Progress of studies on Lonicera hypoglauca Miq. Journal of University of South China f Medical Edition 6,744-746.
Xu, Y., Oliverson, B.G., Simmons, D.L., (2007), Trifunctional inhibition of COX-2 by extracts of Lonicera japonica: direct inhibition, transcriptional and posttranscriptional down regulation, J. Ethnopharmacol 111,667-670.
Yin, S.G., Xin, N., (2007), General situation of studies on Flos Lonicerae. Li Shi-Zhen Medcine and material medical research 12, 2920-2922.
Yoo, H.J., Kang, H.J., Song, Y.S., Park, E.H., Lim, C.J., (2008), Anti-angiogenic, anti-inoceptive and anti-inflammatory activities of Lonicera japonica extract, J. Pharm. Pharmacol 60,779-786.
Xiao-Shun Shu1*, Jin-Hai Lv2, Dong-Ming Chen3, Yun-Hui Chen 4
1, 4 College of Biology & Chemistry Engineering, Changsha University of Science & Technology, Changsha 410114, PR China
2, 3 Department of Biology, Huaihua College, Huaihua 418000, PR China
*Corresponding Author: [email protected]; Tel.: +86 1 13723895338
Received: 30/09/2012; Revised: 15/11/2012; Accepted: 20/11/2012
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright Global Journal of Research on Medicinal Plants & Indigenous Medicine (GJRMI) Dec 2012
Abstract
Lonicera hypoglauca Miq. is used in the traditional medicine for the treatment of sore throat infection, respiratory tract infection and intestinal tract diseases indicating antimicrobial activity. To validate the traditional medicinal claim, in vitro antimicrobial activity of the extracts was screened against eleven human pathogenic bacteria and fungi.The ethyl acetate (EE) and n-butanol (BE) extracts of the flower of Lonicera hypoglauca Miq were tested against five Gram-positive bacteria, five Gram-negative bacteria and five fungi species. Antimicrobial activity was determined by the tube-dilution method. The EE and BE extracts showed antimicrobial activity against all of the tested microorganisms, with minimum inhibitory concentration (MIC) values in the range of 0.32-4.86 mg/ml. The tested microbes Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pneumoniae were highly susceptible to extract BE and antimicrobial activity of extract BE is better than that of extract EE against Staphylococcus aureus and Streptococcus pneumoniae. Both the extracts were found less susceptible against tested fungi. [PUBLICATION ABSTRACT]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer